<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory bowel diseases</z:e>, encompassing <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, are characterised by persistent leucocyte tissue infiltration leading to perpetuation of an inappropriate inflammatory cascade </plain></SENT>
<SENT sid="1" pm="."><plain>The neuronal guidance molecule netrin-1 has recently been implicated in the orchestration of leucocyte trafficking during <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We therefore hypothesised that netrin-1 could modulate leucocyte infiltration and disease activity in a model of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: DSS-<z:hpo ids='HP_0002583'>colitis</z:hpo> was performed in mice with partial genetic netrin-1 deficiency (Ntn-1(+/-) mice) or <z:mp ids='MP_0002169'>wild-type</z:mp> mice treated with exogenous netrin-1 via osmotic pump to examine the role of endogenous and therapeutically administered netrin-1 </plain></SENT>
<SENT sid="4" pm="."><plain>These studies were supported by in vitro models of transepithelial migration and intestinal epithelial barrier function </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Consistent with our hypothesis, we observed induction of netrin-1 during <z:mp ids='MP_0001858'>intestinal inflammation</z:mp> in vitro or in mice exposed to experimental <z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, mice with partial netrin-1 deficiency demonstrated an exacerbated course of DSS-<z:hpo ids='HP_0002583'>colitis</z:hpo> compared to littermate controls, with enhanced <z:hpo ids='HP_0001824'>weight loss</z:hpo> and colonic shortening </plain></SENT>
<SENT sid="7" pm="."><plain>Conversely, mice treated with exogenous mouse netrin-1 experienced attenuated disease severity </plain></SENT>
<SENT sid="8" pm="."><plain>Importantly, permeability studies and quantitative assessment of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> reveal that netrin-1 signalling events do not alter mucosal permeability or intestinal epithelial cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>In vivo studies of leucocyte transmigration demonstrate suppression of neutrophil trafficking as a key function mediated by endogenous or exogenously administered netrin-1 </plain></SENT>
<SENT sid="10" pm="."><plain>Finally, genetic studies implicate the A2B <z:chebi fb="3" ids="16335">adenosine</z:chebi> receptor in netrin-1-mediated protection during DSS-<z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The present study identifies a previously unrecognised role for netrin-1 in attenuating experimental <z:hpo ids='HP_0002583'>colitis</z:hpo> through limitation of neutrophil trafficking </plain></SENT>
</text></document>